Merck & Co., Inc.
MRK · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $17,133 | $365 | $14,526 | $12,358 |
| Dep. & Amort. | $4,499 | $3,872 | $3,909 | $3,214 |
| Deferred Tax | -$1,249 | -$1,899 | -$1,568 | $187 |
| Stock-Based Comp. | $761 | $645 | $541 | $479 |
| Change in WC | -$3,667 | -$2,205 | -$2,782 | -$3,839 |
| Other Non-Cash | $3,991 | $12,228 | $4,469 | $1,710 |
| Operating Cash Flow | $21,468 | $13,006 | $19,095 | $14,109 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,372 | -$3,863 | -$4,388 | -$4,448 |
| Net Acquisitions | -$4,093 | -$12,032 | -$121 | -$12,907 |
| Inv. Purchases | -$519 | -$955 | -$1,204 | -$1 |
| Inv. Sales/Matur. | $377 | $1,658 | $721 | $1,026 |
| Other Inv. Act. | -$127 | $1,109 | $32 | -$225 |
| Investing Cash Flow | -$7,734 | -$14,083 | -$4,960 | -$16,555 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,309 | $4,184 | -$2,251 | $1,631 |
| Stock Issued | $0 | $0 | $384 | $0 |
| Stock Repurch. | -$1,306 | -$1,346 | $0 | -$840 |
| Dividends Paid | -$7,840 | -$7,445 | -$7,012 | -$6,610 |
| Other Fin. Act. | -$195 | -$203 | -$240 | $8,412 |
| Financing Cash Flow | -$7,032 | -$4,810 | -$9,119 | $2,593 |
| Forex Effect | -$293 | $23 | -$410 | -$133 |
| Net Chg. in Cash | $6,409 | -$5,864 | $4,606 | $14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,909 | $12,773 | $8,167 | $8,153 |
| End Cash | $13,318 | $6,909 | $12,773 | $8,167 |
| Free Cash Flow | $18,096 | $9,143 | $14,707 | $9,661 |